|
Satisfai Health Acquires Global License for AI Software to Detect Early Cancer in Barrett’s Esophagus21 Sep 2021
Satisfai Health, a leading medical solutions provider specializing in artificial intelligence (AI) applications, particularly in Gastrointestinal Endoscopy, has acquired an... Continue Reading
|
|
Repligen Announces Agreement to Acquire Avitide Inc.21 Sep 2021
Repligen Corporation (NASDAQ: RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into... Continue Reading
|
|
Argenta Acquires Top Clinical Research Organization Klifovet to Enhance Services and Expand Global Footprint21 Sep 2021
Argenta, the only combined global contract research organization (CRO) and contract development & manufacturing organization (CDMO) dedicated to animal health,... Continue Reading
|
|
Awakn Life Sciences to Acquire Leading Ketamine-Assisted Psychotherapy Clinic in Norway21 Sep 2021
Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (“Awakn” or the “Company”), a biotechnology company developing and delivering... Continue Reading
|
|
Infinity BiologiX Acquires Roylance Pharma21 Sep 2021
IBX, a global leader in biobanking, bioprocessing, and analytics, has acquired UK-based biospecimen storage specialists Roylance Pharma. “We are excited... Continue Reading
|
|
Xeris Pharmaceuticals Stockholders Approve Acquisition of Strongbridge Biopharma21 Sep 2021
Xeris Pharmaceuticals, Inc. (Nasdaq: XERS) (“Xeris”) today announced that its stockholders have voted to approve the previously announced proposed acquisition... Continue Reading
|
|
Syneos Health Acquires StudyKIKAcquisition Offers Sites and Sponsors Access to Technology-Enabled, Insight-Powered Solutions, Accelerating Clinical Trial Recruitment, Retention and Diversity21 Sep 2021
Syneos Health® (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the acquisition of StudyKIK, a leading technology-enabled... Continue Reading
|
|
Symplr to Acquire Halo Health21 Sep 2021
symplr®, the leader in enterprise healthcare operations including governance, risk management and compliance (“GRC”) SaaS solutions, backed by Clearlake Capital... Continue Reading
|
|
AzurRx Biopharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma21 Sep 2021
AzurRx BioPharma Inc. (NASDAQ: AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the development of... Continue Reading
|
|
Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.21 Sep 2021
Mesa Laboratories, Inc. (NASDAQ: MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing... Continue Reading
|